Navigation Links
MiMedx Group Receives HCPCS C-Code from Medicare for EpiFix® Reimbursement
Date:12/5/2011

KENNESAW, Ga., Dec. 5, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has received a transitional pass-through status C-Code from the Centers for Medicare & Medicaid Services ("CMS") for its EpiFix® Amniotic Membrane Allograft.  EpiFix® has been assigned a pass-through status under Medicare's outpatient prospective payment system ("OPPS") effective January 1, 2012. This code will facilitate reimbursement for the application of EpiFix® when used in Medicare patients with chronic wounds. This code will cover the grafts used in treating Medicare patients with dermal wounds in the hospital operating room or a freestanding surgical suite.

Parker H. "Pete" Petit, Chairman and CEO said, "We are very pleased with the CMS decision and their recognition of the therapeutic and financial value that our unique allograft brings to these patients. By making EpiFix® eligible for coverage and reimbursement for the Medicare beneficiaries, these individuals will be able to receive the benefits of this treatment for wounds."

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.  "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix®, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies, processed from the human amniotic membrane, utilize our proprietary Purion® process that was developed by our wholly-owned subsidiary, Surgical Biologics, to produce a safe, effective and minimally manipulated implant. Surgical Biologics is the leading supplier of amniotic tissue, having supplied over 60,000 implants to date to distributors and OEMs for application in the Ophthalmic, Orthopedics, Spine, Wound Care and Dental sectors of healthcare.


'/>"/>
SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MiMedx Group Announces Third Quarter 2011 Results
2. MiMedx Groups EpiFix® Receives American Podiatric Medical Association Seal of Approval
3. MiMedx Group Partners With Affirmative Solutions
4. MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
5. MiMedx Announces Launch of AmnioFix™ Nerve Wrap
6. MiMedx to Attend International Society for the Advancement of Spine Surgery Annual Meeting
7. MiMedx Group, Inc. Announces Release Date for First Quarter Results
8. MiMedx Completes Acquisition of Surgical Biologics
9. MiMedx Receives Additional CE Certification for Its HydroFix™ Technology
10. MiMedx Announces Agreement to Acquire Surgical Biologics
11. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
Breaking Medicine News(10 mins):